[The management of angina pectoris using Ildamen, a new coronary- and cardiac-active substance, in a double-blind study].
D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy*; D002395:Catecholamines / Q000378:metabolism; D002986:Clinical Trials as Topic; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy; D010546:Perphenazine / Q000627:therapeutic use; D010919:Placebos; D013565:Sympatholytics / Q000627:therapeutic use*
D002395:Catecholamines; D010919:Placebos; D013565:Sympatholytics; D010546:Perphenazine
Behandlung der Angina pectoris mit Ildamen, einer neuen koronar- und kerzwirksamen Substanz, im Doppelblindversuch.